Matthew Durstenfeld

Matthew Durstenfeld, MD, MAS is an Assistant Professor of Medicine at the University of California, San Francisco and a practicing general cardiologist at Zuckerberg San Francisco General. His work bridges Cardiovascular Disease, HIV, and Long COVID through clinical research and observational studies.

• MD, University of California, San Francisco
• MAS in Clinical Research

Research focuses on:

• Preventing infection-associated cardiovascular disease
• Global cardiology and health equity
• Robust observational research methods
• Mechanisms of Long COVID in HIV populations

Key article trends include:

• Polypill development for heart failure
• Sex-specific Long COVID manifestations
• Cardiorespiratory fitness in HIV
• AI/automation in safety-net readmissions
• Methamphetamine-associated CVD
• Persistent SARS-CoV-2 viral antigens

Scientific awards include:

• CFAR Mentored Scientist Award (2021)
• K12 Career Development Award
• K23 Career Development Award

Grants and collaborations:

• NIH-funded studies on Long COVID and HIV
• Clinical trials for lipid-lowering therapies, immune-modulators, and vaccines
• Multi-disciplinary team with Cardiology, Infectious Diseases, and Pulmonology

Labs and teams:

• Collaborates with Priscilla Hsue (Cardiology) and Steven Deeks (Infectious Diseases)
• UCSF Cardiology Division
• Zuckerberg San Francisco General clinical teams